Document:

Exhibit 10.9

 

PASITHEA
THERAPEUTICS CORP.

BRIO RETAINER AGREEMENT

STOCK OPTION GRANT NOTICE

 

Pasithea Therapeutics Corp.,
a corporation incorporated under the laws of the State of Delaware (the “Company”), pursuant to the retainer
agreement with Brio Financial Group, LLC dated April 13, 2021 (the “Brio Retainer Agreement”), hereby grants
to the holder listed below (“Grantee”), an option to purchase the number of shares of the Company’s Common
Stock (the “Shares”) set forth below (the “Option”). This Option is subject to all
of the terms and conditions set forth herein and in the Stock Option Agreement, attached hereto (the “Stock Option Agreement”),
and the Brio Retainer Agreement (a copy of which has been provided to Grantee), both of which are incorporated herein in their entirety.
Any capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Brio Retainer Agreement or the Grant
Notice.

 

	
    

    Grantee:
	Stanley M. Gloss
	Grant Date:	[    ], 2021
	Exercise Price per Share:	$[       ]
	Total Exercise Price:	$[       ]
	Total Number of Shares Subject to the Option:	100,000 Shares
	Expiration Date:	90 days after the date of termination of the Brio Retainer Agreement 
	Vesting Schedule:	100% on the Grant Date 
	Type of Option:	Nonqualified Stock Option

 

Additional Terms/Acknowledgements:
Grantee acknowledges receipt of, and understands and agrees to, this Grant Notice, the Stock Option Agreement, and the Brio Retainer Agreement.
Grantee further acknowledges that as of the Grant Date, this Grant Notice, the Stock Option Agreement and the Brio Retainer Agreement
set forth the entire understanding between Grantee and the Company regarding the acquisition of Shares and supersede all prior oral and
written agreements on that subject with the exception of any stock options previously granted and delivered to Grantee under the Brio
Retainer Agreement. Grantee acknowledges receipt of the Company’s prospectus covering the Shares issuable upon exercise of the Option
and that he or she has read and understands such prospectus. Grantee further acknowledges that the Option granted pursuant to the Stock
Option Agreement satisfies in full the Company’s obligations under the Brio Retainer Agreement to provide equity compensation to
Grantee.

 

Please sign one copy of this
Grant Notice (the other copy is for your files) and return the signed copy to me no later than August 30, 2021.

 

	
    PASITHEA THERAPEUTICS
CORP.

    
	 	
    GRANTEE

    

	 	 	 
	By:		 	By:	
	Print Name:	Tiago Reis Marques	 	Print Name:	Stanley M. Gloss
	Title:	Chief Executive Officer	 	  	 

 

     

     

    

 

PASITHEA
THERAPEUTICS CORP.

Brio
Retainer Agreement

 

STOCK
OPTION AGREEMENT

 

Pursuant to your Stock Option
Grant Notice (“Grant Notice”) and this Stock Option Agreement (this “Agreement”),
Pasithea Therapeutics Corp. (the “Company”) has granted you a stock option under the retainer agreement with
Brio Financial Group, LLC dated April 13, 2021 (the “Brio Retainer Agreement”) to purchase the number of shares
of the Company’s Common Stock indicated in your Grant Notice at the Exercise Price indicated in your Grant Notice. Capitalized terms
not defined in this Agreement but defined in the Brio Retainer Agreement shall have the same definitions as in the Brio Retainer Agreement.
For the avoidance of doubt, the terms and conditions of the Grant Notice are a part of this Agreement, unless otherwise specified.

 

The details and terms and
conditions of this Agreement shall govern your Option:

 

1.
Vesting.  

 

(a) The
Option shall become vested and exercisable in the amounts and at the time(s) described in vesting schedule set forth in the Grant Notice.
The Option shall become vested and exercisable only if you continue to regularly perform services for the Company as a director through
the vesting dates set forth in the vesting schedule in Grant Notice. For avoidance of doubt, any unvested portion of the Option may not
be exercised until it becomes vested. For purposes of this Agreement, in the event of an involuntary termination of your covered service
under this Agreement, the termination shall be effective, and vesting shall cease, as of the date stated in the relevant notice of termination
and, unless otherwise required by law, will not be extended by any notice period or other period of leave. Subject to applicable law,
the Company shall determine the date of termination in its sole discretion.

 

2. Method
of Payment. Payment of the aggregate Exercise Price
for the Shares for which the Option is being exercised is due in full upon exercise of all or any part of your vested Option. You may
elect to make payment of such aggregate Exercise Price (i) in cash, (ii) by check or wire transfer, (iii) a cashless exercise on such
terms as may be permitted by the Committee from time to time, or (iv) any other form of exercise as may be permitted by the Committee
from time to time in its sole discretion. 

 

3.
Minimum Exercise. You may exercise your Option only for whole Shares. You must exercise the Option for at least 50 Shares
or, if less, the full number of shares that are vested and exercisable in the vesting schedule in the Grant Notice as to which the
Option remains unexercised.

 

4.
Term. You may not exercise your Option before the Grant Date. If the Option is not exercised with respect to all or any
part of the Shares subject to the Option prior to the expiration date specified in the Grant Notice (which shall be no later than
ten (10) years from the date of grant), the Option shall expire and any Shares with respect to which the Option was not exercised
shall no longer be purchasable under the Option. If you die while performing services to the Company, the appropriate persons
described in Section 6 of this Agreement or persons to whom all or a portion of the Stock Option is transferred in accordance with
Section 5 of this Agreement may exercise the Option at any time within a period ending on the earlier of (a) the last day of the
thirty six (36) month period following death or (b) the expiration date of the Option specified in the Grant Notice. If you
terminate services with the Company and its Affiliates other that on account of death, you may exercise the Option at any time
within a period ending on the earlier of (a) the last day of the three (3) month period following such termination or (b) the
expiration date of the Option specified in the Grant Notice. The period of time during which the Option may be exercised as
described in this Section 5 is referred to in this Agreement as the “Term”. 

 

    2

     

    

 

5. Exercise
Procedures and Suspension. Subject
to Section 7 below and other relevant terms and conditions of the Brio Retainer Agreement and this Agreement, you may exercise the vested
portion of the Options by a written notice signed by you and delivered or mailed to the Company to the attention of the Senior Vice President
of Human Resources such other officer as the Company’s Chief Executive Officer may designate. Any such notice shall (i) specify
the number of Shares which you are electing to purchase, (ii) contain such information as may be reasonably required by the Committee
and (iii) be accompanied by payment in a form acceptable to the Company equal to the total Exercise Price applicable to the Shares being
purchased under the vested portion of the Option subject to this Agreement. Upon receipt of any such notice and accompanying payment,
and subject to the terms hereof, the Company agrees to issue to you the number of Shares specified in such notice registered in the name
of the person exercising the Options (subject to reduction for any Shares used to exercise the Option in a cashless exercise). You acknowledge
that your ability to exercise the Option may be prohibited by the Company’s insider trading policy under certain circumstances.

 

6. Conditions
to Issuance of Stock. The Shares deliverable upon the exercise of the Option, or any portion
thereof, may be either previously authorized but unissued shares or issued shares which have then been reacquired by the Company. Such
Shares shall be fully paid and nonassessable. The Company shall not be required to issue or deliver any Shares purchased upon the exercise
of the Option or portion thereof in book entry or certificated form prior to fulfillment of all of the following conditions:

 

(a) The
completion of any registration or other qualification of such Shares under any state or federal law or under rulings or regulations of
the Securities and Exchange Commission or of any other governmental regulatory body, which the Committee shall, in its absolute discretion,
deem necessary or advisable;

 

(b) The
obtaining of any approval or other clearance from any state or federal governmental agency which the Committee shall, in its absolute
discretion, determine to be necessary or advisable; 

 

(c) The
receipt by the Company of full payment for such Shares, including payment of any withholding tax pursuant to Section 12 below, if applicable,
and 

 

(d) The
receipt by the Company of a lock-up agreement in a form reasonably satisfactory to the Company; and

 

(e) The
lapse of such reasonable period of time following the exercise of the Option as the Committee may from time to time establish for reasons
of administrative convenience.

 

Notwithstanding anything to
the contrary contained herein, you may not exercise your Option if the terms of the Brio Retainer Agreement do not permit the exercise
of Options, or if the Company suspends, delays or restricts the exercise of Options as it deems necessary or appropriate.

 

7.
Documents Governing Issued Common Stock. The Shares that you acquire upon exercise of your Option are subject to the
terms of the Brio Retainer Agreement, the Company’s bylaws, the Company’s certificate of incorporation, any agreement
relating to such Shares to which you become a party, or any other similar document.

 

8.
Limitations on Transfer of Options. Your Option is not transferable, except by will or by the laws of descent and
distribution, and is exercisable during your life only by you. In the event of our death, the administrator or executor shall
thereafter have the right to exercise the Option during the Term.

 

    3

     

    

 

9.
Rights Upon Exercise. You will not have any rights to dividends or other rights of a stockholder with respect to the
Shares subject to the Option until you have given written notice of the exercise of your Option, paid in full for such Shares and,
if applicable, satisfied any other conditions imposed by the Committee pursuant to the Brio Retainer Agreement.

 

10.
Option Is Not a Service Contract. Neither this Agreement nor the Options confer upon you any right with respect to
continuance of services for the Company or its Affiliates in any capacity. 

 

11. Withholding
Obligations. At the time you exercise your Option, in whole or in part, or at any time thereafter
as requested by the Company, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to
make adequate provision for any sums required to satisfy any federal, state, local and foreign tax withholding obligations of the Company
or any of its Affiliates, which arise in connection with your Option. The Committee may, in its sole discretion and in satisfaction of
the foregoing requirement, allow you to elect to have the Company withhold Shares otherwise issuable under this Agreement (or allow the
return of Shares) to satisfy tax withholding obligations. You may not exercise your Option unless the tax withholding obligations of the
Company and/or any Affiliate are satisfied or appropriate arrangements (acceptable to the Company) are made therefor.

 

12. Notices.
Any requests or notices to be given hereunder shall be deemed given, and any elections or exercises to be made or accomplished shall be
deemed made or accomplished, upon actual delivery thereof to the designated recipient, or three days after deposit thereof in the United
States mail, registered, return receipt requested and postage prepaid, addressed, if to you, at the most recent mailing address provided
to the Company in writing, and, if to the Company, to the executive offices of the Company at, 1111 Lincoln
Road Suite 50 Miami Beach, FL 33139 or at such other addresses that the parties provide to each other in accordance with the foregoing
notice requirements.

 

13.
Option Subject to Brio Retainer Agreement. By entering into this Agreement, you agree and acknowledge that you have
received and read a copy of the Brio Retainer Agreement. The Option is subject to the terms and provisions of the Brio Retainer
Agreement and such terms and provisions are hereby incorporated herein by reference. In the event of a conflict between any term or
provision contained herein and a term or provision of the Brio Retainer Agreement, the applicable terms and provisions of the Brio
Retainer Agreement will govern and prevail.  

 

14. Minimum
Stock Ownership.  You acknowledge
and agree that Shares acquired under this Agreement shall be subject to a minimum dollar value stock ownership holding requirement as
may be in effect from time to time. You shall be precluded from settling Shares acquired through equity awards received from the Company,
including this Agreement, having a then value that is equal to or less than the minimum stock ownership amount then in effect. You shall
follow the Company’s pre-clearance requirements prior to any contemplated sale of Company stock in furtherance of the compliance
with this section, the Company’s insider trading policy and any lock-up agreement, and you shall not sell any Shares unless such
sale has been first cleared in advance by the Company. For the avoidance of doubt, any shares acquired by you outside of awards under
the Brio Retainer Agreement shall not be subject to any minimum stock ownership amount as may be in effect from time to time.

 

    4

     

    

 

15. Consent
to Electronic Delivery. In lieu of receiving documents in paper format, you agree, to the fullest
extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, but not
limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly
reports, and all other agreements, forms and communications) in connection with this and any other prior or future incentive award or
program made or offered by the Company or its predecessors or successors. Electronic delivery of a document to you may be via a Company
e-mail system or by reference to a location on a Company intranet site to which you have access.

 

16.
SECTION 409A. For purposes of Section
409A of the Code, this Option is intended to be exempt from Section 409A as a stock right under Treasury Regulation Section 1.409A-1(b)(5).
The Committee may adopt such amendments to the Brio Retainer Agreement and this Agreement, and appropriate policies and procedures, including
amendments and policies with retroactive effect, that the Committee determines necessary or appropriate to preserve the intended treatment
of this Option. 

 

17. Miscellaneous.

 

(a) You
agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company to
carry out the purposes or intent of this Agreement.

 

(b) You
are solely responsible for paying all taxes in connection with the grant and exercise of your Option. 

 

(c) The
waiver by either party of compliance with any provision of this Agreement by the other party shall not operate or be construed as a waiver
of any other provision of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.

 

(d) This
Agreement shall inure to the benefit of and be binding upon the parties hereto and their legal representatives, heirs, and permitted transferees,
successors and assigns.

 

(e) This
Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any conflict
of laws provision or rule.

 

(f) This
Agreement, including those documents and agreements explicitly referenced herein, constitutes the entire agreement between the parties
with respect to the subject matter hereof and supersedes all prior agreements or understandings, whether written or oral. This Agreement
may not be amended, modified or revoked, in whole or in part, except by an agreement in writing signed by each of the parties hereto.

 

(g) You
acknowledge and agree that in the event of a Change in Control, the Committee may take certain actions with respect to the Option and
that the Committee’s actions with respect to your Award may differ from those taken with respect to other Award Agreements or Grantees.

 

(h) To
comply with applicable legal, regulatory, tax or accounting requirements, it may be necessary for the Company or its Affiliates to transfer
certain data to the Company or another Affiliate, or to its outside providers or governmental agencies. By accepting the Option, you consent,
to the fullest extent permitted by law, to the use and transfer, electronically or otherwise, of your personal data to such entities for
such purposes.

 

(i) You
acknowledge that the Option granted pursuant to the Stock Option Agreement satisfies in full the Company’s obligations under the
Brio Retainer Agreement to provide equity compensation to you.

 

    5Exhibit 10.1

 

RBC 2021 LONG-TERM EQUITY INCENTIVE PLAN

 

As of September 8, 2021

 

1. Purpose.
This plan will be known as the RBC 2021 Long-Term Equity Incentive Plan (this “Plan”). The purpose of this Plan
is to promote the long-term growth and profitability of RBC Bearings Incorporated (the “Company”) and its Subsidiaries
by (a) providing certain directors, officers and employees of, and certain other individuals who perform services for, or to whom an offer
of employment has been extended by, the Company and its Subsidiaries with incentives to maximize stockholder value and otherwise contribute
to the success of the Company, and (b) enabling the Company to attract, retain and reward the best available persons for positions of
responsibility. Grants of incentive or non-qualified stock options, stock appreciation rights (either alone or in tandem with options),
restricted stock, performance awards or any combination of the foregoing (“Grants”) may, in the sole discretion of
the Company or its designated delegatee, be made under this Plan.

 

2.
Definitions. For purposes of this Plan, the following words have the following meanings:

 

“409A” means Section 409A of the Code.

 

“Award Agreement” means any
written agreement between the Company and any person pursuant to which the Company makes any Grant under this Plan.

 

“Board of Directors” and “Board”
mean the board of directors of the Company.

 

“Cause” means, unless otherwise
defined in any Award Agreement, the occurrence of one or more of the following events with respect to a Plan participant:

 

(a) conviction
of a felony, or any crime or offense lesser than a felony involving the property of the Company or a Subsidiary, or commission of an act
involving fraud or dishonesty or, in the case of any of the foregoing, a plea of nolo contendere with respect thereto;

 

(b)
conduct that has caused demonstrable and serious injury to the Company or a Subsidiary, reputational, monetary or otherwise;

 

(c)
willful refusal to perform or substantial disregard of duties properly assigned, as determined by the Company;

 

(d)
willful misrepresentation or material non-disclosure to the Board;

 

(e) engaging
willfully in misconduct in connection with the performance of any duties, including, without limitation, the misappropriation of funds
or securing or attempting to secure personally any profit in connection with any transaction entered into on behalf of the Company or
its Subsidiaries or affiliates;

 

(f) willful
breach of duty of loyalty to the Company or a Subsidiary or any other act of disloyalty to the Company or any Subsidiary, including, without
limitation, willfully aiding a competitor or, without duplication of clause (g) below, improperly disclosing confidential information;

 

(g)
willful breach of any confidentiality or non-disclosure agreement with the Company or any Subsidiary; or

 

(h) material
violation of any code or standard of behavior generally applicable to employees (or executive employees, in the case of an executive of
the Company or any Subsidiary) of the Company or any Subsidiary.

 

     

     

    

 

“Change in Control” means, unless otherwise
defined in any Award Agreement,

 

(a) if
any “person” or “group” as those terms are used in Sections 13(d) and 14(d) of the Exchange Act or any successors
thereto, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act or any successor thereto),
directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then
outstanding securities, provided that the acquisition of additional securities by any person or group that owns 50% or more of the voting
power prior to such acquisition of additional securities will not be a Change in Control; or

 

(b) during
any 12-month period, individuals who at the beginning of such period constitute the Board and any new directors whose election by the
Board or nomination for election by the Company’s stockholders was approved by at least a majority of the directors then still in
office who either were directors at the beginning of the period or whose election was previously so approved, cease for any reason to
constitute a majority thereof; or

 

(c) the
stockholders of the Company approve a merger or consolidation of the Company with any other corporation, other than a merger or consolidation
(i) which would result in all or a portion of the voting securities of the Company outstanding immediately prior thereto continuing to
represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the
combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation
or (ii) by which the corporate existence of the Company is not affected and following which the Company’s chief executive officer
and directors retain their positions with the Company (and constitute at least a majority of the Board) and such merger or consolidation
is consummated; or

 

(d) the
stockholders of the Company approve an agreement for the sale or disposition by the Company of all or substantially all the Company’s
assets and such sale or disposition is consummated; or

 

(e) for
the avoidance of doubt, and anything in this Plan or any Award Agreement to the contrary notwithstanding, if a Grant made hereunder is
subject to Section 409A, only to the extent such event constitutes a “change in the ownership or effective control of a corporation
or a change in the ownership of a substantial portion of the assets of a corporation” within the meaning of Section 409A(a)(2)(A)(v)
and guidance issued thereunder.

 

“Code” means the Internal Revenue Code
of 1986, as amended.

 

“Committee” means the Compensation Committee
of the Board, which shall consist solely of two or more outside directors.

 

“Common Stock”
means the common stock, par value $0.01 per share, of the Company, and any other shares into which such stock may be changed by reason
of a recapitalization, reorganization, merger, consolidation or any other change in the corporate structure or capital stock of the Company.

 

“Disability”
means a disability that would entitle an eligible participant to payment of monthly disability payments under any Company disability plan
or as otherwise determined by the Committee; provided that in any instance where a grant to a participant is treated as “deferred
compensation” within the meaning of Section 409A, “Disability” will be interpreted consistently with the meaning of
“disabled” under Section 409A(a)(2)(C) and guidance issued thereunder.

 

“Exchange Act” means the Securities Exchange
Act of 1934, as amended.

 

“Fair Market Value”
of a share of Common Stock means, as of the date in question, the officially-quoted closing selling price of the stock (or if no selling
price is quoted, the bid price) on the principal securities exchange or market on which the Common Stock is then listed for trading (including,
for this purpose, the New York Stock Exchange or the Nasdaq National Market) (the “Market”) for the applicable trading
day or, if the Common Stock is not then listed or quoted in the Market, the Fair Market Value will be the fair value of the Common Stock
determined in good faith by the Board using any reasonable method; provided, however, that when shares received upon exercise of an option
are immediately sold in the open market, the net sale price received may be used to determine the Fair Market Value of any shares used
to pay the exercise price or applicable withholding taxes and to compute the withholding taxes. Anything in this Plan or any Award Agreement
to the contrary notwithstanding, if a Grant to a participant is treated as “deferred compensation” within the meaning of Section
409A, any such determination of Fair Market Value shall be made consistent with and subject to the applicable requirements of Section
409A.

 

“Incentive Stock Option” means an option
conforming to the requirements of Section 422 of the Code and/or any successor thereto.

 

    2

     

    

 

“Non-Employee Director” has the meaning
given to such term in Rule 16b-3 under the Exchange Act and/or any successor thereto.

 

“Non-qualified Stock Option” means any
stock option other than an Incentive Stock Option.

 

“Other Securities”
mean securities of the Company other than Common Stock, which may include, without limitation, debentures, unbundled stock units or components
thereof, preferred stock, warrants and securities convertible into or exchangeable for Common Stock or other property.

 

“Retirement”
means retirement as defined under any Company pension plan or retirement program or termination of one’s employment with the Company
and its Subsidiaries on retirement with the approval of the Committee; provided that in any instance where a grant to a participant is
treated as “deferred compensation” within the meaning of Section 409A, “Retirement” will be interpreted consistently
with the meaning of “separation from service” under Section 409A(a)(2)(A)(i) and guidance issued thereunder.

 

“Subsidiary”
means a corporation or other entity of which outstanding shares or ownership interests representing 50% or more of the combined voting
power of such corporation or other entity entitled to elect the management thereof, or such lesser percentage as may be approved by the
Committee, are owned directly or indirectly by the Company.

 

3. Administration.
This Plan shall be administered by the Committee; provided that the Board may, in its discretion, at any time and from time to time,
resolve to administer this Plan, in which case the term “Committee” will be deemed to mean the Board for all purposes herein.
Subject to the provisions of this Plan, the Committee is authorized to (a) select persons to participate in this Plan, (b) determine the
form and substance of Grants made under this Plan to each participant, and the conditions and restrictions, if any, subject to which such
Grants will be made, (c) certify that the conditions and restrictions applicable to any Grant have been met, (d) modify the terms of Grants
made under this Plan in accordance with the provisions of Sections 16 and 17, (e) interpret this Plan and Grants made thereunder,
(f) make any adjustments necessary or desirable in connection with Grants made under this Plan to eligible participants located outside
the United States, and (g) adopt, amend, or rescind such rules and regulations, and make such other determinations, for carrying out this
Plan as it may deem appropriate. Decisions of the Committee on all matters relating to this Plan shall be in the Committee’s sole
discretion and will be conclusive and binding on all parties. The validity, construction and effect of this Plan and any rules and regulations
relating to this Plan shall be determined in accordance with applicable federal and state laws and rules and regulations promulgated pursuant
thereto. No member of the Committee and no officer of the Company will be liable for any action taken or omitted to be taken by such member,
by any other member of the Committee or by any officer of the Company in connection with the performance of duties under this Plan, except
for such person’s own willful misconduct or as expressly provided by statute. The expenses of this Plan shall be borne by the Company.
The Company will not be required to establish any special or separate fund or make any other segregation of assets to assume the obligations
pursuant to any Grant made under this Plan, and rights to any payment in connection with such Grants will be no greater than the rights
of the Company’s general creditors.

 

4.
Shares Available for this Plan.

 

(a) Subject
to adjustments as provided in Section 15, an aggregate of 1,500,000 shares of Common Stock (the “Shares”) may
be issued pursuant to this Plan. Such Shares may be in whole or in part authorized and unissued or held by the Company as treasury shares.
Notwithstanding anything contained in this Plan to the contrary, if any Grant under this Plan expires or terminates unexercised, becomes
unexercisable or is forfeited as to any Shares, or is tendered or withheld as to any Shares in payment of the exercise price of the Grant
or taxes payable with respect to the Grant or the vesting or exercise thereof, then such unpurchased, forfeited, tendered or withheld
Shares may not thereafter be available for further Grants under this Plan. The number of shares that may be used for restricted stock
or restricted unit grants under this Plan may not exceed 50% of the total authorized number of Shares pursuant to this Plan. A restricted
stock and stock option grant to an eligible individual under this Plan for a year cannot exceed 100,000 shares.

 

(b) Without
limiting the generality of the foregoing provisions of this Section 4 or the generality of the provisions of Sections 3,
6 or 17 or any other section of this Plan, the Committee may, at any time or from time to time, and on such terms and conditions
(that are consistent with and not in contravention of the other provisions of this Plan) as the Committee may, in its sole discretion,
determine, enter into agreements (or take other actions with respect to the Grants) for new Grants containing terms (including exercise
prices) more (or less) favorable than the outstanding Grants.

 

5.
Participation.

 

(a) Participation
in this Plan is limited to those directors (including Non-Employee Directors), officers (including non-employee officers) and employees
of, and other individuals performing services for, or to whom an offer of employment has been extended by, the Company and its Subsidiaries
selected by the Committee (including participants located outside the United States). Nothing in this Plan or in any Grant thereunder
will confer any right on a participant to continue in the employ as a director or officer of, or in any other capacity or in the performance
of services for, the Company or will interfere in any way with the right of the Company to terminate the employment or performance of
services or to reduce the compensation or responsibilities of a participant at any time. By accepting any Grant under this Plan, each
participant and each person claiming under or through him or her will be conclusively deemed to have indicated his or her acceptance and
ratification of, and consent to, any action taken under this Plan by the Company, the Board or the Committee.

 

    3

     

    

 

(b) Incentive
Stock Options or Non-qualified Stock Options, SARs alone or in tandem with options, restricted stock awards, performance awards or any
combination thereof may be granted to such persons and for such number of Shares as the Committee shall determine (such individuals to
whom Grants are made being sometimes herein called “optionees” or “grantees,” as the case may be). Determinations
made by the Committee under this Plan need not be uniform and may be made selectively among eligible individuals under this Plan, whether
or not such individuals are similarly situated. A Grant of any type made hereunder in any one year to an eligible participant will neither
guarantee nor preclude a further Grant of that or any other type to such participant in that year or subsequent years.

 

6.
Incentive and Non-qualified Options and SARs.

 

(a) General.
The Committee may from time to time grant to eligible participants Incentive Stock Options, Non-qualified Stock Options, or any combination
thereof; provided that the Committee may grant Incentive Stock Options only to eligible employees of the Company or its subsidiaries (as
defined for this purpose in Section 424(f) of the Code or any successor thereto). In any one calendar year and subject to the limitations
prescribed in Section 4(a), the Committee may not grant to any one participant options or SARs to purchase or receive the economic
equivalent of a number of shares of Common Stock in excess of 10% of the total number of Shares authorized under this Plan, provided that
the Committee will be permitted to grant to Dr. Michael J. Hartnett up to 60% of the total number of Shares authorized under this Plan
at any time. The options granted will take such form as the Committee shall determine, subject to the terms and conditions of this Section
6.

 

(b) Incentive
Stock Options. It is the Company’s intent that (i) Non-qualified Stock Options granted under this Plan not be classified as
Incentive Stock Options, (ii) Incentive Stock Options be consistent with and contain or be deemed to contain all provisions required under
Section 422 of the Code or any successor thereto, (iii) neither any Non-qualified Stock Option nor any Incentive Stock Option be treated
as a payment of deferred compensation for the purposes of Section 409A and any successor thereto, and (iv) any ambiguities in construction
be interpreted in order to effectuate such intent. If an Incentive Stock Option does not qualify as such for any reason, then to the extent
of such non-qualification, the stock option represented thereby will be regarded as a Non-qualified Stock Option, provided that such stock
option otherwise meets this Plan’s requirements for Non-qualified Stock Options.

 

(c) Price.
The price per Share deliverable upon the exercise of each option (i.e., the exercise price) may not be less than 100% of the Fair
Market Value of a share of Common Stock as of the date of Grant of the option, and in the case of the Grant of any Incentive Stock Option
to an employee who, at the time of the Grant, owns more than 10% of the total combined voting power of all classes of stock of the Company
or any of its Subsidiaries, the exercise price may not be less than 110% of the Fair Market Value of a share of Common Stock as of the
date of Grant of the option, in each case unless otherwise permitted by Section 422 of the Code or any successor thereto.

 

(d)
Payment.

 

(i) Options
may be exercised, in whole or in part, upon payment of the exercise price of the Shares to be acquired. Unless otherwise determined by
the Committee, payment shall be made (A) in cash (including check, bank draft, money order or wire transfer of immediately available funds),
(B) by delivery of outstanding shares of Common Stock with a Fair Market Value on the date of exercise equal to the aggregate exercise
price payable with respect to the options being exercised, (C) by simultaneous sale, through a broker reasonably acceptable to the Committee,
of Shares acquired on exercise as permitted under Regulation T of the Federal Reserve Board, (D) by authorizing the Company to withhold
from issuance a number of Shares issuable upon exercise of the options that, when multiplied by the Fair Market Value of a share of Common
Stock on the date of exercise, is equal to the aggregate exercise price payable with respect to the options so exercised or (E) by any
combination of the foregoing. For the avoidance of doubt, an option shall not include any feature for the deferral of compensation other
than the deferral of recognition of income until the exercise of the option.

 

    4

     

    

 

(ii) In
the event a grantee elects to pay the exercise price payable with respect to an option pursuant to clause (B) of Section 6(d)(i),
(A) only a whole number of share(s) of Common Stock (and not fractional shares of Common Stock) may be tendered in payment, (B) such grantee
must present evidence acceptable to the Company that he or she has owned any such shares of Common Stock tendered in payment of the exercise
price (and that such tendered shares of Common Stock have not been subject to any substantial risk of forfeiture) for at least six months
prior to the date of exercise, and (C) Common Stock must be delivered to the Company. Delivery for this purpose may, at the election of
the grantee, be made either by (x) physical delivery of the certificate(s) for all such shares of Common Stock tendered in payment of
the price, accompanied by duly executed instruments of transfer in a form acceptable to the Company, or (y) direction to the grantee’s
broker to transfer, by book entry, such shares of Common Stock from a brokerage account of the grantee to a brokerage account specified
by the Company. When payment of the exercise price is made by delivery of Common Stock, the difference, if any, between the aggregate
exercise price payable with respect to the option being exercised and the Fair Market Value of the shares of Common Stock tendered in
payment (plus any applicable taxes) shall be paid in cash. No grantee may tender shares of Common Stock having a Fair Market Value exceeding
the aggregate exercise price payable with respect to the option being exercised (plus any applicable taxes).

 

(iii) In
the event a grantee elects to pay the exercise price payable with respect to an option pursuant to clause (D) of Section 6(d)(i),
only a whole number of Shares (and not fractional Shares) may be withheld in payment. When payment of the exercise price is made by withholding
of Shares, the difference, if any, between the aggregate exercise price payable with respect to the option being exercised and the Fair
Market Value of the Shares withheld in payment (plus any applicable taxes) shall be paid in cash. No grantee may authorize the withholding
of Shares having a Fair Market Value exceeding the aggregate exercise price payable with respect to the option being exercised (plus any
applicable taxes). Any withheld Shares will no longer be issuable under such option.

 

(e) Terms
of Options; Vesting. The term during which each option may be exercised shall be determined by the Committee, but if required by the
Code and except as otherwise provided herein, no option may be exercisable in whole or in part more than seven years from the date it
is granted, and no Incentive Stock Option granted to an employee who at the time of the Grant owns more than 10% of the total combined
voting power of all classes of stock of the Company or any of its Subsidiaries may be exercisable more than five years from the date it
is granted. All rights to purchase Shares pursuant to an option will, unless sooner terminated, expire at the date designated by the Committee.
The Committee shall determine the date on which each option will become exercisable and may provide that an option will become exercisable
in installments. The Shares constituting each installment may be purchased in whole or in part at any time after such installment becomes
exercisable, subject to such minimum exercise requirements as may be designated by the Committee. Prior to the exercise of an option and
delivery of the Shares represented thereby, the optionee will have no rights as a stockholder with respect to any Shares covered by such
outstanding option (including any dividend or voting rights).

 

(f) Limitations
on Grants. If required by the Code, the aggregate Fair Market Value (determined as of the Grant date) of Shares for which an Incentive
Stock Option is exercisable for the first time during any calendar year under all equity incentive plans of the Company and its subsidiaries
(as defined in Section 422 of the Code or any successor thereto) may not exceed $100,000.

 

(g)
Termination; Forfeiture.

 

(i) Death
or Disability. Unless otherwise provided in any Award Agreement, if a participant ceases to be a director, officer or employee of,
or to perform other services for, the Company and any Subsidiary due to death or Disability, (A) all of the participant’s options
and SARs that were exercisable on the date of death or Disability will remain exercisable for, and will otherwise terminate at the end
of, a period of one year after the date of death or Disability, but in no event after the expiration date of the options and SARs, and
(B) all of the participant’s options and SARs that were not exercisable on the date of death or Disability will be forfeited immediately
upon such death or Disability; provided, however, that the Committee may determine to additionally vest such options and SARs, in whole
or in part, in its discretion. Notwithstanding the foregoing, if the Disability giving rise to the termination of employment is not within
the meaning of Section 22(e)(3) of the Code or any successor thereto, Incentive Stock Options not exercised by such participant within
one year after the date of termination of employment will cease to qualify as Incentive Stock Options and will be treated as Non-qualified
Stock Options under this Plan if required to be so treated under the Code.

 

(ii) Retirement.
Unless otherwise provided in any Award Agreement, if a participant ceases to be a director, officer or employee of, or to perform other
services for, the Company and any Subsidiary upon the occurrence of his or her Retirement, (A) all of the participant’s options
and SARs that were exercisable on the date of Retirement will remain exercisable for, and will otherwise terminate at the end of, a period
of 90 days after the date of Retirement, but in no event after the expiration date of the options or SARs, and (B) all of the participant’s
options and SARs that were not exercisable on the date of Retirement will be forfeited immediately upon such Retirement, provided that
such options and SARs may become fully vested and exercisable (subject to the 90-day limitation period described in clause (A) above)
in the discretion of the Committee. Notwithstanding the foregoing, Incentive Stock Options not exercised by such participant within 90
days after Retirement will cease to qualify as Incentive Stock Options and will be treated as Non-qualified Stock Options under this Plan
if required to be so treated under the Code.

 

    5

     

    

 

(iii) Discharge
for Cause. Unless determined by the Committee, if a participant ceases to be a director, officer or employee of, or to perform other
services for, the Company or a Subsidiary due to Cause, or if a participant does not become a director, officer or employee of, or does
not begin performing other services for, the Company or a Subsidiary for any reason, all of the participant’s options and SARs will
expire and be forfeited immediately upon such cessation or non-commencement, whether or not then exercisable.

 

(iv) Other
Termination. Unless determined by the Committee, if a participant ceases to be a director, officer or employee of, or to otherwise
perform services for, the Company or a Subsidiary for any reason other than death, Disability, Retirement or Cause, (A) all of the participant’s
options and SARs that were exercisable on the date of such cessation will remain exercisable for, and will otherwise terminate at the
end of, a period of 90 days after the date of such cessation, but in no event after the expiration date of the options or SARs, and (B)
all of the participant’s options and SARs that were not exercisable on the date of such cessation will be forfeited immediately
upon such cessation.

 

7.
Stock Appreciation Rights.

 

(a) Provided
that the Company’s stock is traded on an established securities market, the Committee will have the authority to grant SARs under
this Plan, subject to such terms and conditions specified in this Section 7 and any additional terms and conditions as the Committee
may specify.

 

(b) No
SAR may be issued unless (i) the exercise price of the SAR may never be less than the Fair Market Value of the underlying Shares on the
date of grant and (ii) the SAR does not include any feature for the deferral of compensation income other than the deferral of recognition
of income until the exercise of the SAR.

 

(c) No
SAR may be exercised unless the Fair Market Value of a share of Common Stock of the Company on the date of exercise exceeds the exercise
price of the SAR. Prior to the exercise of the SAR and delivery of the Shares represented thereby, the participant will have no rights
as a stockholder with respect to Shares covered by such outstanding SAR (including any dividend or voting rights).

 

(d) Upon
the exercise of an SAR, the participant will be entitled to a distribution in an amount equal to the difference between the Fair Market
Value of a share of Common Stock on the date of exercise and the exercise price of the SAR, multiplied by the number of Shares as to which
the SAR is exercised. Such distribution will be made in Shares having a Fair Market Value equal to such amount.

 

(e) All
SARs will be exercised automatically on the last day prior to the expiration date of the SAR so long as the Fair Market Value of a share
of Common Stock on that date exceeds the exercise price of the SAR or any related option, as applicable.

 

(f) The
provisions of Sections 6(e) will apply to all SARs except to the extent that the Award Agreement pursuant to which such Grant is
made expressly provides otherwise.

 

(g) It
is the Company’s intent that no SAR will be treated as a payment of deferred compensation for purposes of Section 409A and that
any ambiguities in construction be interpreted in order to effectuate such intent.

 

8.
Restricted Stock.

 

(a) The
Committee may at any time and from time to time grant Shares of restricted stock under this Plan to such participants and in such amounts
as it determines. Each Grant of restricted stock shall specify the applicable restrictions on such Shares, the duration of such restrictions,
and the time or times at which such restrictions will lapse with respect to all or a specified number of Shares that are part of the Grant.

 

(b) The
participant will be required to pay the Company the aggregate par value of any Shares of restricted stock (or such larger amount as the
Board may determine to constitute capital under Section 154 of the Delaware General Corporation Law, as amended, or any successor thereto)
within 15 days of the date of Grant, unless such Shares of restricted stock are treasury shares. Unless otherwise determined by the Committee,
certificates representing Shares of restricted stock granted under this Plan will be held in escrow by the Company on the participant’s
behalf during any period of restriction thereon and will bear an appropriate legend specifying the applicable restrictions thereon, and
the participant will be required to execute a blank stock power therefor. Except as otherwise provided by the Committee, during such period
of restriction the participant will have all of the rights of a holder of Common Stock, including but not limited to the rights to receive
dividends and to vote, and any stock or other securities received as a distribution with respect to such participant’s restricted
stock will be subject to the same restrictions as then in effect for the restricted stock.

 

    6

     

    

 

(c) Unless
otherwise provided in any Award Agreement, at such time as a participant ceases to be a director, officer or employee of, or to otherwise
perform services for, the Company and its Subsidiaries due to death, Disability or Retirement during any period of restriction, all Shares
of restricted stock granted to such participant on which the restrictions have not lapsed will be immediately forfeited to the Company.
At such time as a participant ceases to be, or in the event a participant does not become, a director, officer or employee of, or otherwise
perform services for, the Company or its Subsidiaries for any other reason, all Shares of restricted stock granted to such participant
on which the restrictions have not lapsed will be immediately forfeited to the Company. The provisions of Sections 6(e) and 6(g)
will apply to Restricted Stock except to the extent that the Award Agreement in relation thereto expressly provides otherwise.

 

(d) It
is the Company’s intent that Restricted Stock will not be treated as a payment of deferred compensation for purposes of Section
409A and that any ambiguities in construction be interpreted in order to effectuate such intent.

 

9.
Performance Awards.

 

(a) Performance awards may be
granted to participants at any time and from time to time as determined by the Committee. The Committee will have complete discretion
in determining the size and composition of performance awards granted to a participant. The period over which performance is to be measured
(a “performance cycle”) will commence on the date specified by the Committee and will end on the last day of a fiscal year
specified by the Committee. The Committee intends that performance awards shall be structured to comply with the short-term deferral
exception or another exemption to Section 409A, and all applicable vesting and payment terms shall be specified in individual Award Agreements.
Performance awards may include (i) specific dollar-value target awards, (ii) performance units, the value of each such unit being determined
by the Committee at the time of issuance, and/or (iii) performance Shares, the value of each such Share being equal to the Fair Market
Value of a share of Common Stock. In any one calendar year, the Committee may not grant to any one participant performance awards in
excess of 10% of the total number of Shares authorized under this Plan, provided that the Committee will be permitted to grant to Dr.
Michael J. Hartnett up to 60% of the total number of Shares authorized under this Plan at any time.

 

(b) The
value of each performance award may be fixed or it may be permitted to fluctuate based on a performance factor (e.g., return on
equity) selected by the Committee. It is the Company’s intent that no performance award will be treated as the payment of deferred
compensation for purposes of Section 409A and that any ambiguities in construction be interpreted in order to effectuate such intent.

 

(c) The
Committee shall establish performance goals and objectives for each performance cycle on the basis of such criteria and objectives as
the Committee may select from time to time, including, without limitation, the performance of the participant, the Company, one or more
of its Subsidiaries or divisions, or any combination of the foregoing. During any performance cycle, the Committee will have the authority
to adjust the performance goals and objectives for such cycle for such reasons as it deems equitable.

 

(d) The
Committee shall determine the portion of each performance award that is earned by a participant on the basis of the Company’s performance
over the performance cycle in relation to the performance goals for such cycle. The earned portion of a performance award may be paid
out in Shares, cash, Other Securities, or any combination thereof, as the Committee may determine.

 

(e) A
participant must be a director, officer or employee of, or otherwise perform services for, the Company or its Subsidiaries at the end
of the performance cycle in order to be entitled to payment of a performance award issued in respect of such cycle, provided that, except
as otherwise determined by the Committee, if a participant ceases to be a director, officer or employee of, or to otherwise perform services
for, the Company and its Subsidiaries upon his or her death, Retirement, or Disability prior to the end of the performance cycle, the
Committee may provide in a Grant that the participant may earn a proportionate portion of the performance award based upon the elapsed
portion of the performance cycle and the Company’s performance over that portion of such cycle.

 

    7

     

    

 

10.
Withholding Taxes.

 

(a) Participant
Election. Unless otherwise determined by the Committee, a participant may elect to deliver shares of Common Stock (or have the Company
withhold shares acquired upon exercise of an option or SAR or deliverable upon grant or vesting of restricted stock, as the case may be)
to satisfy, in whole or in part, the amount the Company is required to withhold for taxes in connection with the exercise of an option
or SAR or the delivery of restricted stock upon grant or vesting, as the case may be. Such election must be made on or before the date
the amount of tax to be withheld is determined. Once made, the election will be irrevocable. The fair market value of the shares to be
withheld or delivered will be the Fair Market Value as of the date the amount of tax to be withheld is determined. In the event a participant
elects to deliver or have the Company withhold shares of Common Stock pursuant to this Section 10(a), such delivery or withholding
must be made subject to the conditions and pursuant to the procedures set forth in Section 6(d) with respect to the delivery or
withholding of Common Stock in payment of the exercise price of options. For the avoidance of doubt, a participant may also elect to pay
withholding taxes in cash.

 

(b) Company
Requirement. The Company may require, as a condition to any Grant or exercise under this Plan or to the delivery of certificates for
Shares issued hereunder, that the grantee make provision for the payment to the Company, either pursuant to Section 10(a) or this
Section 10(b), of federal, state or local taxes of any kind required by law to be withheld with respect to any Grant or delivery
of Shares. The Company, to the extent permitted or required by law, will have the right to deduct from any payment of any kind (including
salary or bonus) otherwise due to a grantee, an amount equal to any federal, state or local taxes of any kind required or permitted by
law to be withheld with respect to any grant or delivery of Shares under this Plan.

 

11. Written
Agreement. Each employee to whom a Grant is made under this Plan shall enter into an Award Agreement with the Company containing
such provisions consistent with the provisions of this Plan as may be approved by the Committee. If there is a Change in Control, the
Committee may, in its discretion, provide a provision in any participant’s Award Agreement for the vesting of such participant’s
Grant under this Plan if the participant ceases to be a director, officer, employee or individual performing services for the Company
because his or her relationship with the Company is terminated without Cause following a Change in Control, with such vesting to occur
on the date of termination.

 

12. Transferability.
Unless the Committee determines otherwise, no option, SAR, performance award or restricted stock granted under this Plan will be transferable
by a participant other than by will or the laws of descent and distribution, provided that, in the case of Shares of restricted stock
granted under this Plan, such Shares of restricted stock will be freely transferable following the time at which such restrictions have
lapsed with respect to such Shares. Unless the Committee determines otherwise, an option, SAR or performance award may be exercised only
by the optionee or grantee thereof or by (a) his or her executor or administrator, the executor or administrator of the estate of any
of the foregoing, or any person to whom the option, SAR or performance award is transferred by will or the laws of descent and distribution,
(b) his or her guardian or legal representative, or (c) the guardian or legal representative of any of the foregoing, provided that Incentive
Stock Options may be exercised by any guardian or legal representative only if permitted by the Code and any regulations thereunder. All
provisions of this Plan and any Award Agreement will in any event continue to apply to any option, SAR, performance award or restricted
stock granted under this Plan and transferred as permitted by this Section 12, and any transferee of any such option, SAR, performance
award or restricted stock will be bound by all provisions of this Plan and such Award Agreement as and to the same extent as the applicable
original grantee.

 

13. Listing,
Registration and Qualification. If the Committee determines that the listing, registration or qualification upon any securities
exchange or under any law of Shares subject to any option, SAR, performance award or restricted stock Grant is necessary or desirable
as a condition of, or in connection with, the granting of the same or the issue or purchase of Shares thereunder, no such option or SAR
may be exercised in whole or in part, no such performance award may be paid out, and no Shares may be issued, unless such listing, registration
or qualification is effected free of any conditions not acceptable to the Committee.

 

14. Transfer
of Employee. The transfer of an employee from the Company to a Subsidiary, from a Subsidiary to the Company, or from one Subsidiary
to another will not be considered a termination of employment; nor will it be considered a termination of employment if an employee is
placed on military or sick leave or such other leave of absence that is considered by the Committee as continuing intact the employment
relationship.

 

    8

     

    

 

15.
Adjustments.

 

(a) In
the event of a reorganization, recapitalization, stock split, stock dividend, combination of shares, merger, consolidation, distribution
of assets, spin-off or other extraordinary distribution, or any other change in the corporate structure or shares of the Company, the
Committee shall make such adjustment as it deems appropriate in the number and kind of Shares or other property available for issuance
under this Plan (including, without limitation, the total number of Shares available for issuance under this Plan pursuant to Section
4), in the number and kind of options, SARs, Shares or other property covered by Grants previously made under this Plan, and in the
exercise price of outstanding options and SARs. Any such adjustment will be final, conclusive and binding for all purposes of this Plan.
In the event of any merger, consolidation or other reorganization in which the Company is not the surviving or continuing corporation
or in which a Change in Control is to occur, all of the Company’s obligations regarding options, SARs, performance awards, and restricted
stock that were granted hereunder and that are outstanding on the date of such event will, on such terms as may be approved by the Committee
prior to such event, be (i) assumed by the surviving or continuing corporation, or (ii) canceled in exchange for cash, securities of the
acquiror or other property, provided that, in the case of clause (ii), (A) such merger, consolidation, other reorganization or Change
in Control constitutes a “change in ownership or control” of the Company or a “change in the ownership of a substantial
portion” of the Company’s assets within the meaning of Section 409A(a)(2)(A)(v) and the guidance issued thereunder or (B)
the payment of cash, securities or other property is not treated as a payment of “deferred compensation” under Section 409A.

 

(b) Without
limitation of the foregoing, in connection with any transaction described in the last sentence of Section 15(a), the Committee
may, in its discretion, (i) cancel any or all outstanding options under this Plan in consideration for payment to the holders thereof
of an amount equal to the portion of the consideration that would have been payable to such holders pursuant to such transaction if their
options had been fully exercised immediately prior to such transaction, less the aggregate exercise price that would have been payable
therefor, or (ii) if the amount that would have been payable to the option holders pursuant to such transaction if their options had been
fully exercised immediately prior thereto would be equal to or less than the aggregate exercise price that would have been payable therefor,
cancel any or all such options for no consideration or payment of any kind. Payment of any amount payable pursuant to the preceding sentence
may be made in cash or, in the event that the consideration to be received in such transaction includes securities or other property,
in cash, securities of the acquiror or other property in the Committee’s discretion.

 

(c) Notwithstanding
the foregoing: (i) any adjustments made pursuant to this Section 15 to Grants that are considered “deferred compensation”
within the meaning of Section 409A shall be made in compliance with the requirements of Section 409A, (ii) any adjustments made pursuant
to this Section 15 to Grants that are not considered “deferred compensation” subject to Section 409A shall be made
in such a manner as to ensure that, after such adjustment, the Grants either (A) continue not to be subject to Section 409A, or (B) comply
with the requirements of Section 409A, and (iii) in any event, the Company and the Committee will not have any authority to make any adjustments
pursuant to this Section 15 to the extent the existence of such authority would cause a Grant that is not intended to be subject
to Section 409A at the Grant Date to be subject thereto as of the Grant Date.

 

16. Amendment
and Termination of this Plan. Except as otherwise provided in an Award Agreement, the Board of Directors, without approval of
the stockholders, may amend or terminate this Plan, except that no amendment will become effective without prior approval of the stockholders
of the Company if stockholder approval would be required by applicable law or regulations, including if required (a) under the provisions
of Section 409A or any successor thereto, (b) under the provisions of Section 422 of the Code or any successor thereto, or (c) by any
listing requirement of the principal stock exchange on which the Common Stock is then listed.

 

17. Amendment
or Substitution of Grants under this Plan. The terms of any outstanding Grant under this Plan may be amended from time to time
by the Committee in its discretion in any manner that it deems appropriate, including acceleration of the date of exercise of any Grant
and/or payments thereunder or of the date of lapse of restrictions on Shares (but, in the case of a Grant that is or would be treated
as “deferred compensation” for purposes of Section 409A, only to the extent permitted by guidance issued under Section 409A),
provided that, except as otherwise provided in Section 16 or in an Award Agreement, no such amendment may adversely affect in a
material manner any right of a participant under the Grant without his or her written consent, and further provided that the Committee
may not reduce the exercise price of any options or SARs awarded under this Plan. The Committee may, in its discretion, permit holders
of Grants under this Plan to surrender outstanding Grants in order to exercise or realize rights under other Grants, or in exchange for
new Grants, or require holders of Grants to surrender outstanding Grants as a condition precedent to the receipt of new Grants under this
Plan, but only if such surrender, exercise, realization, exchange or Grant is (a) not treated as a payment of, and does not cause a Grant
to be treated as, deferred compensation for purposes of Section 409A or (b) permitted under guidance issued pursuant to Section 409A.
Notwithstanding anything contained in this Section 17 to the contrary, no surrender, exercise, realization, exchange or Grant in
substitution for, assumption of, or as an alternative to or replacement of, an existing Grant pursuant to this Section 17 may be
effected or implemented by the Company, including a cash buy-back of an out-of-the-money stock option, in order to (i) reduce or change
the exercise price of any outstanding options or SARs awarded under this Plan or (ii) otherwise implement a re-pricing of any outstanding
options or SARs awarded under this Plan, including by means of buy-back, cancellation and re-grant.

 

    9

     

    

 

18. Commencement
Date; Termination Date. The date of commencement of this Plan will be September 8, 2021, subject to approval by the stockholders
of the Company. Unless previously terminated upon the adoption of a resolution of the Board terminating this Plan, this Plan will terminate
at the close of business on September 8, 2031. Subject to the provisions of an Award Agreement, which may be more restrictive, no termination
of this Plan may materially and adversely affect any of the rights or obligations of any person, without his or her written consent, under
any Grant of options or other incentives theretofore granted under this Plan.

 

19. Severability.
Whenever possible, each provision of this Plan will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Plan is held to be prohibited by or invalid under applicable law, such provision will be ineffective only
to the extent of such prohibition or invalidity, without invalidating the remainder of this Plan.

 

20. Governing
Law. This Plan will be governed by the corporate laws of the State of Delaware, without giving effect to any choice of law provisions
that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction.

 

21. Compliance
Amendments. Except as otherwise provided in an Award Agreement, notwithstanding any of the foregoing provisions of this Plan,
and in addition to the powers of amendment set forth in Sections 16 and 17, the provisions hereof and the provisions of
any award made hereunder may be amended unilaterally by the Company from time to time to the extent necessary (and only to the extent
necessary) to prevent the implementation, application or existence (as the case may be) of any such provision from (a) requiring the inclusion
of any compensation deferred pursuant to the provisions of this Plan (or an award thereunder) in a participant’s gross income pursuant
to Section 409A, and the regulations issued thereunder from time to time and/or (b) inadvertently causing any award hereunder to be treated
as providing for the deferral of compensation pursuant to such Code section and regulations.

 

22. Code
Section 409A Generally. It is intended that the payments and benefits provided under this Plan and any Grant will either be exempt
from the application of, or comply with, the requirements of Section 409A. This Plan and all Award Agreements will be construed in a manner
that effects such intent. Nevertheless, the tax treatment of the benefits provided under this Plan or any Award Agreement is not warranted
or guaranteed. Subject to the applicable requirements of Section 10 and the Company acting in its role as withholding agent, neither
the Company, its Subsidiaries nor their respective directors, officers, employees or advisers will be held liable for any taxes, interest,
penalties or other monetary amounts owed by any participant or other taxpayer as a result of this Plan or any Award. Any payments described
in this Plan that are due within the “short-term deferral period” as defined in Section 409A will not be treated as deferred
compensation. Notwithstanding anything to the contrary in this Plan, to the extent required to avoid accelerated taxation and tax penalties
under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this Plan during
the six-month period immediately following a participant’s separation from service shall instead be paid on the first payroll date
after the six-month anniversary of the participant’s separation from service (or the participant’s death, if earlier). Notwithstanding
the foregoing, neither the Company nor the Committee will have any obligation to take any action to prevent the assessment of any additional
tax or penalty on any participant under Section 409A and neither the Company nor the Committee will have any liability to any participant
for such tax or penalty.

 

 

10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]